Ted Allrich
-

Intel Corp. (INTC) raised its dividend. Again. The 14th time since 1992 when it began paying quarterly sums to investors. The annual payout is now 63 cents or 15.75 cents every three months. That's 12.5% higher than the previous dividend.

The stock is trading around $20 a share. With a 63 cent dividend, that's a yield of 3%. Not a bad return when coupled with the 50% rise the stock's seen in the past year.

The dollar doesn't buy what it used to, especially if it's something made in another country. When the dollar is weak, imports cost more because it takes more dollars to buy a foreign product. And the weak dollar is just the way our government likes it.

That's because the other side of the dollar bill is that when it's weak, U.S. products become cheaper for other countries to buy. While China is having a resurgence in its economy, it will buy more goods and services, many of them from the U.S. Our stuff is a bargain because it doesn't take as many renminbi to buy dollars. U.S. manufacturers take their renminbi, buy dollars and repatriot the money. They still make the same profit on the product and enjoy stronger sales, due to the weak dollar.

Warrent Buffett, investor extraordinaire, just bought something. The Burlington Northern Santa Fe Railroad Company (BNI). It cost $26 billion. He already owned part of the railroad, but he wanted it all. Figured it was a great investment. So why should you care?

First, because it's Warren Buffett. While he's made one or two bad investments (see Eastern Airlines (who?) as an example), most of what Mr. Buffett buys increases in value. He's not the second richest man in America because he's lucky. When he buys into an industry, it may be one that most investors should consider.

The federal pay czar is doing his job. He's cutting enormous paydays for executives of banks and other institutions that took TARP money. That's as it should be. Those banks performed terribly. Several would have simply vanished if the government hadn't bailed them out. Since capitalism is all about rewarding risk and merit, these executives don't deserve extraordinary payments.

But there is a concern that investors need to think about. It has to do with the human side of this equation. Consider this: if you're an executive who has a contract that states exactly how you get paid and you meet those standards, you would expect payment. That's why there are contracts. You and your department may have been one of the few groups that contributed to earnings, helping mitigate some of the losses other departments generated. While you may feel a twinge of "team" spirit and be glad that you've helped, you don't feel it deeply enough to believe your contract should be violated.

Apple Inc. (NASDAQ: AAPL) just reported unbelievably good earnings in an unbelievably bad economy. Fiscal fourth quarter results were up 46% compared to the same quarter last year. Investors liked what they saw and pushed the stock over $200 a share in after market trading. How can Apple deliver great earnings while almost everyone else is struggling?

Investors can learn a lot from studying Apple and applying it to all their stocks. While it is a high tech company, it has attributes that all great companies share. Here are some of them.

Many investors need income, especially as they reach retirement. They look for ancillary cash flow to supplement their Social Security payments and any retirement benefits from a company for which they've worked. But those aren't the only investors who should be interested in income.

That's because studies show that dividends are a significant contributor to overall performance of a stock. When held for years, a stock's dividend can help diminish the volatility of a stock's price and keep returns reasonable, especially in down markets. Here are five stocks that have decent income as well as potential capital gains. All are exceptionally financially strong.

Want to know if your stock is overpriced, maybe ready to take a breather? Then check its PEG. That's Price to Earnings to Growth, or the P/E ratio divided by the growth rate of a company's earnings. It's a quick and easy way to see if your stock may be ahead of its earnings power. It's also one measure a lot of momentum investors rely on as a screening tool.

If a stock's P/E ratio is well above its growth rate, they believe the stock is overpriced and won't touch it. But if the p/e ratio is well below the stock's growth rate, it could signal a bargain. It helps to know your stock's PEG.

No one thinks good times are here again. Unemployment is too high and will most likely get worse before everyone agrees that the recession is over. (If you're one of the many jobless who have been looking for months for a job, this is a depression, not a recession.)

No, times aren't good yet. But there are signs, both anecdotal and data driven, that show the worst is most likely over. Many of these signs aren't very visible. They don't make headlines, yet they do give credence to the idea that consumers are starting to spend, that the economy has stopped its downward spiral.

We're wrapping up the third quarter soon. Earnings will be out in October for most companies, certainly the largest names. They should look very good ... when compared to the third quarter of last year. And the fourth quarter will most likely look even better when comparisons are made.

There's the rub. The percentage increase in earnings will be strong for most companies as many of them wrote down assets, especially in the financials, last year at this time. Mortgages that weren't paying, loans that were way past due, they were losses. Every kind of asset a bank or thrift owned was under scrutiny. Many financials bit the bullet and wrote off large numbers, to get the bad news out of the way. Others nibbled at it, stretching out the pain over several quarters. By now many of those write offs have been taken, and those kinds of losses will be lighter, making earnings much better.

There may be a new rule coming from the Fed that will make banks stronger but will hurt investors. There's a good possibility that banks will have to raise their "well-capitalized" capital requirement from 7% to 8%. The current definition of "well-capitalized" is 6% but the unofficial rate that regulators like to see is 7%. That means for every asset on the books of $100, there is now $7 of capital to back it up. With the new rule, that capital cushion would go to $8. That means the FDIC would have more protection against losses ($8 of protection is better than $7). But the question is: where do banks find the extra $1?

They can come up with it several different ways, none of which help current investors. The first, and easiest way, is to simply sell assets and lower the total size of the bank. If a bank of $1 billion has capital of $70 million, it could sell enough assets to shrink to $875 million. Then the capital base stays the same at $70 million (assuming no gain or loss on the sale of the assets) but the percentage of capital is now 8% rather than 7%.

Mergers and acquisitions are hitting the headlines. Walt Disney Co. (NYSE: DIS) just bought Marvel Entertainment for $4 billion. The biggest one recently is the Kraft Foods (NYSE: KFT) bid for Cadbury's at $16.73 billon. It wasn't accepted, but that doesn't mean it won't eventually happen. And Hershey Co (NYSE: HSY) certainly isn't going sit idly by and watch what happens. It may have ideas of its own for Cadbury.

You may think these big deals have no connection to your stocks since you don't own them. But you're wrong. This M & A activity has a very positive influence on all stocks, directly and indirectly. The more mergers there are, the better the stock market will do.

Unlike Commissioner Gordon who can send out the Bat signal to call his helpmate against crime, there is nothing investors can do to summon aid in times of stress. They have to go it alone. But they can be armed with intelligence that helps. Here are few of the most prominent data points that will make a difference for all stocks, a macro perspective that should make navigating the stock market highway a little easier.

However, taken on a one-time basis, these aren't going to solve the mystery that is the market. Rather, data has to show a trend before it can be used. Even then, a trend stops and another begins. So even though the trend can be your friend, it can just as easily turn and become your enemy. As they used to say on Hill Street Blues: Be careful out there.

We've seen the market move up in a rather dramatic way since March, which is somewhat logic defying because most of the news has been bad over that time.

Certainly earnings weren't anything to shout about, but many of the forecasts sounded optimistic. Unemployment keeps growing. That's never good for the market. Housing lately is starting to find footing, stopping the continuous slide of lower prices, but over the last 18 months it's been in a depression. So with all the bad news, can the market keep its momentum?

Most likely it will. That's because the market looks ahead by at least six to nine months, and ignores the here and now. With the latest economic data and the re-appointment of Benjamin Bernanke as the Fed chief, investors have reason to believe there are numbers, not just hope, behind the latest market moves.

Most investors got slammed last year, down 50% or more in their investments. Didn't matter if they owned stocks or real estate, they got hammered. Many have to start over. And if they're near retirement, it's scary. Years of patient investing wiped out, gains that were made over a long time disappeared frighteningly fast.

But now it's time to begin fresh, to rebuild. What's the safest way to regain some or all of the losses without suffering another wipeout?

Biotechs are fascinating. They have such great promise, yet very few of them actually turn those promises into money. Cures for all types of cancers always seem imminent with promising (there's that word again) results from mice or small control groups. Phase I testing is completed and all kinds of good stuff seems possible. Then something usually happens. Usually not very good things.

Most of the time, it's discovered that what works in mice doesn't work in men (or women). Or that the group was too small for meaningful data and when a larger group is studied, the efficacy isn't there. Or as soon as there's a bounce in the stock price, much more stock is issued and dilution occurs.